Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy (Q37240466)

19 August 2017

Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy (English)

1 reference

19 August 2017

1 reference

4

Monica Morrow

1 reference

19 August 2017

Robin M Ciocca

1

1 reference

19 August 2017

Tianyu Li

series ordinal

2

1 reference

19 August 2017

Gary M Freedman

series ordinal

3

1 reference

19 August 2017

28 May 2008

1 reference

Annals of Surgical Oncology

19 August 2017

1 reference

19 August 2017

15

1 reference

19 August 2017

2263-2271

1 reference

19 August 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1245/s10434-008-9960-8

19 August 2017

0 references

cites work

The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2701545

Loss of heterozygosity in lobular carcinoma in situ of the breast

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2701545

Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2701545

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2701545

The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2701545

E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2701545

Lobular neoplasia (so-called lobular carcinoma in situ) of the breast

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2701545

Lobular carcinoma in situ of the breast Detailed analysis of 99 patients with average follow-up of 24 years

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2701545

Lobular carcinoma in situ: A rare form of mammary cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2701545

Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2701545

Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2701545

Improving local control with breast-conserving therapy: a 27-year single-institution experience

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2701545

Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2701545

Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2701545

Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2701545

The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18506537

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Lobular carcinoma in situ as a component of breast cancer: the long-term outcome in patients treated with breast-conservation therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18506537

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18506537

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1245/S10434-008-9960-8

1 reference

Dimensions Publication ID

19 August 2017

0 references

1 reference

19 August 2017

1 reference